These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 7482124

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
    Maclean R, Meiklejohn D, Soutar R.
    Br J Haematol; 1996 Mar; 92(3):768-9. PubMed ID: 8616054
    [No Abstract] [Full Text] [Related]

  • 4. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
    Hamblin TJ, Orchard JA, Myint H, Oscier DG.
    J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
    [No Abstract] [Full Text] [Related]

  • 5. Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia.
    Ford CD, Asch J, Pulsipher M, Petersen FB.
    Br J Haematol; 2004 Aug; 126(4):623-4. PubMed ID: 15287959
    [No Abstract] [Full Text] [Related]

  • 6. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment.
    Tosti S, Caruso R, D'Adamo F, Picardi A, Ali Ege M, Girelli G, Mauro FR, Maurillo L, Amadori S.
    Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584
    [No Abstract] [Full Text] [Related]

  • 7. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H, Murase T, Ueno H, Park JW, Yano T, Ikeda Y.
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
    Smolej L.
    Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
    [No Abstract] [Full Text] [Related]

  • 12. Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
    Syed NN, Khurshid M.
    J Pak Med Assoc; 2006 Jan; 56(1):44-5. PubMed ID: 16454137
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O, Yürekli BS, Pürnak T, Aksu S, Haznedaroglu IC.
    Ann Pharmacother; 2004 Jan; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
    Vick DJ, Byrd JC, Beal CL, Chaffin DJ.
    Vox Sang; 1998 Jan; 74(2):122-6. PubMed ID: 9501412
    [Abstract] [Full Text] [Related]

  • 18. Evan's syndrome precipitated by fludarabine therapy in a case of CLL.
    Sen K, Kalaycio M.
    Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320
    [No Abstract] [Full Text] [Related]

  • 19. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Antich Rojas J, Balaguer H, Cladera A.
    Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.